Watch NHC. Know when insiders buy.
One email the day a filing lands. Free.
Work order
36
FLAG · insiders 25, shorts 47
Insiders, 90 days
−$2.3M
net selling · 0 buys, 9 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.4BP/E 24.6DIV YIELD 1.18%FCF YIELD 4.28%REV TTM $1.6B +6.9%NET INCOME $140.3M +33.8%NET DEBT $791K52W 113.42 – 236.75SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $408M | +8.8% | — | $48.9M | $40.3M | +70.0% | 2.54 | $43.3M | $12.5M | $30.7M | Aug 6 |
| Q1 2026 · Mar 31 | $381.8M | +2.2% | — | $32.3M | $35.9M | +11.3% | 2.27 | $62.5M | $9.6M | $52.9M | Aug 6 |
| Q4 2025 · Dec 31derived | $386.5M | +4.6% | — | $33.1M | $24.8M | +308.6% | 1.57 | $16.8M | $10.4M | $6.4M | Feb 26 |
| Q3 2025 · Sep 30 | $382.7M | +12.5% | — | $30.4M | $39.2M | −8.3% | 2.50 | $66.2M | $9.7M | $56.5M | Nov 6 |
| Q2 2025 · Jun 30 | $374.9M | +24.7% | — | $34.1M | $23.7M | −11.6% | 1.52 | $62.8M | $10.2M | $52.6M | Aug 6 |
| Q1 2025 · Mar 31 | $373.7M | +25.7% | — | $30.8M | $32.2M | +22.9% | 2.07 | $39.3M | $6.1M | $33.1M | Aug 6 |
| Q4 2024 · Dec 31derived | $369.4M | +22.7% | — | $28.9M | $6.1M | −78.6% | 0.38 | $12.8M | $8.2M | $4.6M | Feb 26 |
| Q3 2024 · Sep 30 | $340.2M | +17.9% | — | $22.8M | $42.8M | +311.9% | 2.73 | $34.2M | $5.7M | $28.6M | Nov 6 |
| Q2 2024 · Jun 30 | $300.7M | — | — | $22.5M | $26.8M | — | 1.73 | $50.7M | $7.8M | $42.8M | Nov 6 |
| Q1 2024 · Mar 31 | $297.2M | — | — | $15.7M | $26.2M | — | 1.69 | $9.6M | $6M | $3.7M | Nov 6 |
| Q4 2023 · Dec 31derived | $300.9M | — | — | $20.4M | $28.4M | — | 1.84 | $25.7M | $8.6M | $17.1M | Feb 26 |
| Q3 2023 · Sep 30 | $288.5M | — | — | $13M | $10.4M | — | 0.68 | $32.3M | $6.5M | $25.8M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.5B | — | $128.4M | $120M | 7.9% | 7.67 | $185.1M | $36.4M | $148.6M | $14.7M | $38.7M |
| FY2024 · to Dec 31 | $1.3B | — | $89.9M | $101.9M | 7.8% | 6.53 | $107.3M | $27.6M | $79.7M | $13.5M | $37M |
| FY2023 · to Dec 31 | $1.1B | — | $57.5M | $66.8M | 5.9% | 4.34 | $111.2M | $27.9M | $83.3M | $2.5M | $35.6M |
| FY2022 · to Dec 31 | $1.1B | — | $31.9M | $22.4M | 2.1% | 1.45 | $8.7M | $30.2M | −$21.5M | $9.9M | $34.6M |
| FY2021 · to Dec 31 | $1.1B | — | $50.9M | $138.6M | 12.9% | 8.99 | $62.4M | $39.4M | $23M | $836K | $32M |
| FY2020 · to Dec 31 | $1B | — | $48.2M | $41.9M | 4.1% | 2.72 | $203.3M | $21.9M | $181.4M | $53K | $31.9M |
Every number comes from NATIONAL HEALTHCARE CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.